# Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants

> **NCT02396147** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 54 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TAK-385 T2 Formulation
- **DRUG:** TAK-385 T4 Formulation B
- **DRUG:** TAK-385 T4 Formulation C

## Key facts

- **NCT ID:** NCT02396147
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2015-04
- **Final completion:** 2015-06
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2016-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02396147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02396147, "Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02396147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*